• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Piperlonguminine

Piperlonguminine

Product ID P3563
Cas No. 5950-12-9
Purity ≥99%
Product Unit SizeCostQuantityStock
10 mg $92.00 In stock
25 mg $173.70 In stock
100 mg $510.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Piperlonguminine is found in several species of the Piper plant and displays many beneficial characteristics, including antithrombotic, anti-inflammatory, anti-hyperlipidemic, antibacterial, anti-parasitic, antifungal, neuroprotective, and anticancer chemotherapeutic activities. In animal models, piperlonguminine inhibits generation of factor Xa and thrombin and production of TNF-α-induced plasminogen activator inhibitor type 1 (PAI-1), increasing bleeding time. This compound decreases PMA-stimulated phosphorylation or activation of NF-κB, p38, ERK1/2, and JNK and also decreases levels of IL-6 and TNF-α. In other animal studies, piperlonguminine increases LDL receptor mRNA and decreases total serum cholesterol (including an increase in HDL and decreases in LDL and triglyceride levels). Piperlonguminine also promotes adipogenesis, increasing mRNA levels of adiponectin, glutamate transporter 4 (GLUT4), fatty acid binding protein aP2, and PPARγ in vitro. This compound displays cytotoxicity against gram-positive bacteria (Bacillus), parasites (Trypanosoma cruzi), and fungus (Candida). Piperlonguminine decreases levels of amyloid-B (Aβ) and amyloid precursor protein (APP) in vitro, suggesting potential benefit in the treatment of Alzheimer’s disease. Additionally, piperlonguminine decreases tumor growth in animal models.

Product Info

Cas No.

5950-12-9

Purity

≥99%

Formula

C16H19NO3

Formula Wt.

273.33

Chemical Name

(2E, 4E)-5-Benzo[d][1,3]-dioxol-5-yl)-N-isobutylpenta-2,4-dienamide

IUPAC Name

(2E,4E)-5-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)penta-2,4-dienamide

Melting Point

168-169°C

Solubility

DMSO

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

P3563 MSDS PDF

Info Sheet

P3563 Info Sheet PDF

References

Lee W, Yoo H, Ku SK, et al. Anticoagulant activities of piperlonguminine in vitro and in vivo. BMB Rep. 2013 Oct;46(10):484-9. PMID: 24148768.

Ku SK, Kim JA, Bae JS. Piperlonguminine Downregulates Endothelial Protein C Receptor Shedding In Vitro and In Vivo. Inflammation. 2013 Oct 15. [Epub ahead of print]. PMID: 24127121.

Lee W, Yoo H, Kim JA, et al. Barrier protective effects of piperlonguminine in LPS-induced inflammation in vitro and in vivo. Food Chem Toxicol. 2013 Aug;58:149-57. PMID: 23619565.

Yamaguchi I, Matsuda H, Zhang H, et al. Adipogenic effects of piperlonguminine in 3T3-L1 cells and plasma concentrations of several amide constituents from Piper chaba extracts after treatment of mice. J Nat Med. 2013 Apr 13. [Epub ahead of print]. PMID: 23584920.

Bao L, Borjihan G. Hypolipidemic effects of piperlonguminine in HepG2 cells and in Wistar rats. Pharmazie. 2012 Oct;67(10):858-61. PMID: 23136721.

Qi HS, Liu P, Gao SQ, et al. Inhibitory effect of piperlonguminine/ dihydropiperlonguminine on the production of amyloid beta and APP in SK-N-SH cells. Chin J Physiol. 2009 Jun 30;52(3):160-8. PMID: 19777802.

Silva DR, Endo EH, Filho BP, et al. Chemical Composition and Antimicrobial Properties of Piper ovatum Vahl. Molecules. 2009 Mar 16;14(3):1171-82. PMID: 19325517

Bezerra DP, Pessoa C, Moraes MO, et al. In vivo growth inhibition of sarcoma 180 by piperlonguminine, an alkaloid amide from the Piper species. J Appl Toxicol. 2008 Jul;28(5):599-607. PMID: 17975786.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • S1604

    Secretin Acetate

    Endogenous peptide hormone, involved in feeding...

    ≥95%
  • M1749

    Memantine Hydrochloride

    D2 agonist, NMDA, 5-HT3, α7 nAChR antagonist.<...

    ≥97%
  • S8110

    Sucralfate

    Antacid; pepsin inhibitor. Assay (Polysaccharid...

    Assay (Polysaccharide sulfate) 30-38%
  • C2468

    β-Calcitonin Gene Related Peptide, human

    Endogenous calcitonin-family peptide, involved ...

    ≥98%
  • G0175

    Gastric Inhibitory Peptide, human

    Endogenous peptide hormone, somatostatin analog...

    ≥95%
  • A6922

    Arformoterol Tartrate

    R,R enantiomer of formoterol; β2-adrenergic an...

    ≥98%
  • D183740

    Desoxypipradrol

    NDRI inhibitor

    ≥98%
  • T0299

    Tazobactam Sodium

    β-lactamase inhibitor.

    ≥98%
  • V182685

    Verdinexor

    CRM1/XPO1 inhibitor.

    ≥99%
  • E6245

    Eplerenone

    Mineralocorticoid antagonist.

    ≥99%
  • C002041

    Cabazitaxel

    Taxoid that disrupts the microtubular network i...

    ≥98%
  • A081014

    Acalabrutinib

    Inhibitor of Bruton’s tyrosine kinase (BTK).<...

    ≥99%
  • G8101

    Guaifenesin

    Expectorant.

    ≥98%
  • C0167

    Carbenoxolone

    Synthetic glycyrrhetinic acid derivative; 11β-...

    ≥98%
  • N1656

    D-(+)-Neopterin

    Endogenous pteridine metabolite of GTP.

    ≥98%
  • N3301

    Niacin

    Vitamin B, required for formation of NAD and NA...

    ≥98%
  • I4961

    Imperatorin

    Furocoumarin; voltage-gated Na+ channel blocker...

    ≥98%
  • C0006

    Cabozantinib

    VEGFR2, c-Met, RET inhibitor.

    ≥98%
  • C5970

    Corydaline

    Alkaloid compound found in Corydalis.

    ≥94%
  • I0800

    IC-87114

    p110δ PI3K inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only